School of Medicine
Showing 1-10 of 38 Results
-
Eitan Yaffe
Affiliate, Medicine - Med/Infectious Diseases
Bio I'm interested to expand our understanding of the interplay between the evolution of microbial communities and horizontal gene transfer, with an emphasis the dissemination of antimicrobial resistance determinants within and between microbial communities.
In my current position I am a research associate in the lab of Prof. David Relman. I study strain dynamics and evolution during antibiotic treatment in healthy adults. -
Zheng Yan
Stanford Student Employee, Sean N. Parker Center for Allergy and Asthma Research - Lab
Current Role at Stanford I'm currently working part time for Dr. Kari Nadeau in the Pulmonary and Critical Care department as a bioinformatician - I get lots of awesome immunological data to work with R. My most recent project involves a study on twins, with the goal of correlating environmental factors with variations in cell frequency, serum proteins, and cytokine activation. I am mentored by Dr. Sandra Andorf.
-
Mi Yang
Postdoctoral Research Fellow, Oncology
Bio I am a bioinformatics scientist working in cancer immunotherapy. Originally trained as a pharmacist, I then did a PhD in machine learning applied to cancer drug screenings. My main areas of interest are: cancer immunotherapy and drug discovery. I am currently developing a reverse translational framework for drug discovery in DLBCL and building an interaction network to capture tumor microenvironment signaling and cell cell interactions. My overarching goal is to develop new immunotherapies for cancer and make the drug development process more efficient, rational and data driven.
-
Phillip C. Yang, MD
Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.
